IP Library Granted Patent US 9,096,644
Granted Patent B2
US 9,096,644 · App. 13/924,906 · Granted Aug 4, 2015

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

Inventors: Ming Tan (Cincinnati, OH); Xi Jiang (Cincinnati, OH)
Assignee: Children's Hospital Medical Center
C07K7/06A61K38/00A61K39/12A61K39/125C07K5/10A61K2039/5258A61K2039/542A61K2039/543A61K2039/55566A61K2039/58A61K2039/6075A61K2039/645A61K2039/70C12N2720/12334C12N2770/16034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,096,644
App. No.
13/924,906
Granted
Aug 4, 2015
Kind
B2
Abstract

A substituted Norovirus capsid protein monomer, having only the P-domain, includes a foreign antigen inserted into one or more of three surface loops present on each P-domain monomer by molecular cloning. The antigen-P-domain monomer can assemble spontaneously into an octahedral, antigen-Norovirus P-particle, composed of 24 copies of the monomer. Each substituted P-domain monomer can contain one to three copies of the foreign antigen, for a total of 24-72 antigen copies on each antigen-P-particle. The antigen-P-particle is useful in methods for diagnosing, immunizing and treating individuals infected with a foreign virus and as a carrier for development of vaccines against many infectious and non-infectious diseases. The substituted monomer can be readily produced in E. coli and yeast, are highly stable and tolerate a wide range of physio-chemical conditions. The P-particle-VP8 chimeras may also serve as a dual vaccine, for example, against both rotavirus and norovirus.

Claims (3)

1. A method of inducing an immune response in a mammal against a viral antigen, comprising the step of administering to the mammal an effective amount of an immunogenic composition comprising an antigen-P-particle consisting of 24 monomers, said P-particle including at least one antigen-P-domain monomer, wherein the antigen-P-particle can enhance the immunogenicity of the antigen as compared to said antigen along;

wherein said at least one antigen P-domain monomer comprises a Norovirus (NOR) P-domain monomer having at least one surface loop and a foreign protein or polypeptide antigen inserted into said at least one surface loop.

2. The method according to claim 1 , wherein the foreign protein or polypeptide antigen is rotovirus (RV) VP8 antigen, thereby forming a P-particle-VP8 chimera, which serves as an immunogenic composition against both rotavirus and norovirus.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 23, 2017
From: CINCINNATI CHILDRENS HOSP MED CTR
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041060/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2013
From: JIANG, XI; TAN, MING
To: CHILDREN'S HOSPITAL MEDICAL CENTER
Reel/Frame 030765/0380 →
Continuity (4)
Continuation 12797396 · Jun 9, 2010
Provisional Application 61185564 · Jun 9, 2009
Provisional Application 61224696 · Jul 10, 2009
Related Publication 20130273090A1 · Oct 17, 2013